Current status of the evaluation of LAAM as a maintenance drug for heroin addicts.
D000293:Adolescent; D000328:Adult; D001773:Blood Cells / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D001853:Bone Marrow / Q000187:drug effects; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006556:Heroin Dependence / Q000534:rehabilitation*; D006787:Hospitals, Veterans; D006801:Humans; D008297:Male; D008691:Methadone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008692:Methadyl Acetate / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D010352:Patient Dropouts; D011674:Pulse / Q000187:drug effects; D012107:Research Design; D013997:Time Factors
D008692:Methadyl Acetate; D008691:Methadone